Goldman Sachs’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Sell |
405,748
-1,306,367
| -76% | -$933K | ﹤0.01% | 4541 |
|
|
2025
Q1 | $1.11M | Sell |
1,712,115
-2,307
| -0.1% | -$1.5K | ﹤0.01% | 3737 |
|
|
2024
Q4 | $3.15M | Sell |
1,714,422
-31,846
| -2% | -$58.6K | ﹤0.01% | 3192 |
|
|
2024
Q3 | $6.04M | Buy |
1,746,268
+696,896
| +66% | +$2.41M | ﹤0.01% | 2623 |
|
|
2024
Q2 | $3.07M | Buy |
1,049,372
+246,637
| +31% | +$723K | ﹤0.01% | 2948 |
|
|
2024
Q1 | $4.54M | Sell |
802,735
-257,847
| -24% | -$1.46M | ﹤0.01% | 2645 |
|
|
2023
Q4 | $4.55M | Sell |
1,060,582
-30,809
| -3% | -$132K | ﹤0.01% | 2665 |
|
|
2023
Q3 | $3.79M | Sell |
1,091,391
-7,483
| -0.7% | -$26K | ﹤0.01% | 2673 |
|
|
2023
Q2 | $5.11M | Sell |
1,098,874
-401,739
| -27% | -$1.87M | ﹤0.01% | 2558 |
|
|
2023
Q1 | $6.93M | Buy |
1,500,613
+423,145
| +39% | +$1.95M | ﹤0.01% | 2282 |
|
|
2022
Q4 | $8.71M | Buy |
1,077,468
+136,897
| +15% | +$1.11M | ﹤0.01% | 2230 |
|
|
2022
Q3 | $5.22M | Buy |
940,571
+434,511
| +86% | +$2.41M | ﹤0.01% | 2601 |
|
|
2022
Q2 | $2.64M | Buy |
506,060
+103,679
| +26% | +$540K | ﹤0.01% | 3227 |
|
|
2022
Q1 | $3.31M | Buy |
402,381
+39,828
| +11% | +$327K | ﹤0.01% | 3144 |
|
|
2021
Q4 | $5.4M | Buy |
362,553
+36,396
| +11% | +$542K | ﹤0.01% | 2739 |
|
|
2021
Q3 | $6.16M | Buy |
326,157
+274,151
| +527% | +$5.18M | ﹤0.01% | 2641 |
|
|
2021
Q2 | $967K | Sell |
52,006
-21,387
| -29% | -$398K | ﹤0.01% | 4040 |
|
|
2021
Q1 | $1.67M | Sell |
73,393
-59,474
| -45% | -$1.35M | ﹤0.01% | 3521 |
|
|
2020
Q4 | $2.89M | Buy |
132,867
+114,723
| +632% | +$2.49M | ﹤0.01% | 2841 |
|
|
2020
Q3 | $182K | Sell |
18,144
-22,442
| -55% | -$225K | ﹤0.01% | 4092 |
|
|
2020
Q2 | $315K | Buy |
40,586
+26,652
| +191% | +$207K | ﹤0.01% | 3802 |
|
|
2020
Q1 | $142K | Buy |
13,934
+2,405
| +21% | +$24.5K | ﹤0.01% | 4069 |
|
|
2019
Q4 | $127K | Buy |
+11,529
| New | +$127K | ﹤0.01% | 4098 |
|
|
2018
Q4 | – | Sell |
-28,300
| Closed | -$425K | – | 4239 |
|
|
2018
Q3 | $425K | Buy |
+28,300
| New | +$425K | ﹤0.01% | 3512 |
|